Home > Insider Trading > Filing (0001181431-14-034521)

Filing Details

Accession Number:: 0001181431-14-034521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-20 19:55:18
Reporting Period:: 2014-10-16

Filing Date:: 2014-10-20
Accepted Time:: 2014-10-20 19:55:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124140	Exact Sciences Corp	EXAS	Services-Commercial Physical & Biological Research (8731)	204782291

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306119	T Kevin Conroy	C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-16	133,333	$0.83	278,896	No	4	M	Direct
Common Stock	Disposition	2014-10-16	133,333	$22.84	145,563	No	4	S	Direct
Common Stock	Acquisiton	2014-10-17	133,333	$0.83	278,896	No	4	M	Direct
Common Stock	Disposition	2014-10-17	133,333	$23.68	145,563	No	4	S	Direct
Common Stock	Acquisiton	2014-10-20	133,334	$0.83	278,897	No	4	M	Direct
Common Stock	Disposition	2014-10-20	133,334	$23.93	145,563	No	4	S	Direct
Common Stock	Acquisiton	2014-10-20	135,000	$0.83	280,563	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-10-16	133,333	$0.00	2,500,000	$0.83
Common Stock	Stock Option (right to buy)	Disposition	2014-10-17	133,333	$0.00	2,366,667	$0.83
Common Stock	Stock Option (right to buy)	Disposition	2014-10-20	133,334	$0.00	2,233,334	$0.83
Common Stock	Stock Option (right to buy)	Disposition	2014-10-20	135,000	$0.00	2,100,000	$0.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,366,667	2013-03-18	2019-03-18	No	4	M	Direct
2,233,334	2013-03-18	2019-03-18	No	4	M	Direct
2,100,000	2013-03-18	2019-03-18	No	4	M	Direct
1,965,000	2013-03-18	2019-03-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,531	Indirect	Held in 401(K) Account

Footnotes

The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares effected pursuant to the 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of trades for all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.